Hua Fu | Organic Chemistry | Best Researcher Award

Published on by China Scientist

Prof. Dr. Hua Fu | Organic Chemistry | Best Researcher Award

Hua Fu is a Professor of Organic Chemistry at Tsinghua University. He earned his B.S. in Chemistry from Wuhan University and his Ph.D. from Tsinghua University in 1998 under Prof. Yufen Zhao. From 2000 to 2002, he conducted postdoctoral research at The Ohio State University with Prof. Dehua Pei. His research focuses on chiral ligands and catalysts, bioorthogonal reactions, and photocatalysts. With over 240 publications, he has made significant contributions to the field of organic chemistry.

Prof. Dr. Hua Fu | Tsinghua University/Department of Chemistry | China

Profile

SCOPUS ID

ORCID ID

🎓Education

  • Hua Fu obtained his Bachelor of Science degree in Chemistry from Wuhan University, China. He then pursued his doctoral studies at Tsinghua University, China, where he earned his Ph.D. in 1998 under the guidance of Professor Yufen Zhao.

👨‍🏫Experience

  • Following his Ph.D., Hua Fu conducted postdoctoral research at The Ohio State University from 2000 to 2002, working with Professor Dehua Pei in the Department of Chemistry. After completing his postdoctoral studies, he returned to China and began his independent academic career at the Department of Chemistry at Tsinghua University. He currently serves as a full professor in the department.

🏆Awards and Recognitions

  • Throughout his distinguished career, Hua Fu has received numerous awards and honors in recognition of his contributions to the field of organic chemistry. His work has been widely cited, and he has established himself as a leading researcher in his domain.

💡Skills and Certifications

  • Hua Fu possesses extensive expertise in organic chemistry, with a strong background in catalysis, bioorthogonal chemistry, and photocatalysis. His research involves the development of innovative chiral ligands and catalysts, as well as advanced chemical reaction mechanisms.

🔬 Research Focus

  • His current research interests span several cutting-edge areas of chemistry, including the development of chiral ligands and catalysts, bioorthogonal reactions, and the design of novel photocatalysts. With more than 240 published papers, his work continues to have a significant impact on the field of organic chemistry.

🌎Conclusion

  • Given his outstanding research contributions, academic leadership, and impact on organic chemistry, Hua Fu is a highly deserving candidate for the Research for Best Researcher Award. His work continues to drive advancements in the field, making a lasting impact on both scientific research and practical applications in chemistry..

📖Publications

  • Staudinger Cleavages of Amides on Naphthalene for the Ipsilateral Effect of 1,8-Substituents
    Authors: Lunyu Ou, Zhengyi Yi, Yue Zhang, Yufen Zhao, Hua Fu
    Journal: Organic Letters, 2024

  • Sodium Trifluoromethanesulfinate-Mediated Photocatalytic Aerobic Oxidative Esterification of Aromatic Aldehydes and Alcohols
    Authors: Yong Liu, Xianjin Zhu, Yue Zhang, Xiaobo Yang, Hua Fu
    Journal: Organic and Biomolecular Chemistry, 2024

  • All-in-One Rh(III)-Covalent Organic Framework for Sustainable and Regioselective C(sp²)-H Bond Functionalization
    Authors: Luohe Wang, Junnan E., Xiubin Bu, Hua Fu, Zhen Zhao
    Journal: Catalysis Science and Technology, 2024

  • Visible Light-Driven Flexible Synthesis of α-Alkylated Glycine Derivatives Catalyzed by Reusable Covalent Organic Frameworks
    Authors: Yao Tian, Xiubin Bu, Luohe Wang, Hua Fu, Zhen Zhao
    Journal: Journal of Organic Chemistry, 2024

  • Visible Light-Promoted Goldberg Reaction Driven by a Preponderant Facet of CuO Nanocrystals
    Authors: Ze Xu, Weiwei Wang, Yuanqing Xu, Hua Fu, Zhenxing Li
    Journal: ACS Catalysis, 2023

Jinming Zhou | Medicinal Chemistry | Best Researcher Award

Published on by China Scientist

Dr. Jinming Zhou | Medicinal Chemistry| Best Researcher Award

Research and Grant Success:

  • Dr. Zhou’s research has been consistently supported by prestigious National Natural Science Foundation (NCSF) grants, with four approvals to date. This grant success not only reflects the high quality and impact of his research but also indicates his capacity to conduct rigorous and relevant studies that address critical health challenges.
Dr. Jinming Zhou, Zhejiang Normal University , China

Profile

Scopus

OrcID

🌱EARLY ACADEMIC PURSUITS

  • Dr. Zhou’s academic journey began at Beijing Normal University, where he earned his Bachelor of Science (B.S.) in 2000 and Master of Science (M.S.) in 2003. His passion for rational drug design led him to pursue a Ph.D. at the Shanghai Institute of Organic Chemistry, where he specialized in this field, establishing a strong foundation in medicinal chemistry. Postdoctoral training followed at McGill University in Canada, where he continued advancing in rational drug design and gained international research exposure.

💼 PROFESSIONAL ENDEAVORS

  • In 2010, Dr. Zhou joined the Institute of Medicinal Biotechnology at the Chinese Academy of Medical Science as an Associate Professor. Demonstrating outstanding contributions in drug research, he achieved full professorship in 2017. His career took a new turn in 2018 when he accepted a professorship at Zhejiang Normal University, where he also became the Director of the Drug Development and Innovation Center. Dr. Zhou’s leadership at this center has been pivotal in establishing innovative practices and groundbreaking projects.

🔬CONTRIBUTIONS AND RESEARCH FOCUS 

  • Dr. Zhou’s research team is at the forefront of developing anti-viral and anti-cancer drugs. His group combines rational drug design and applied medicinal research to create effective therapeutic solutions. His work has a special emphasis on translational medicine, aiming to bridge scientific research and clinical applications. He has secured four prestigious National Natural Science Foundation (NCSF) grants, supporting his work in advancing therapeutic drug development.

📚ACADEMIC CITES 

  • With over a hundred publications, Dr. Zhou has significantly impacted medicinal chemistry, particularly in antiviral and anticancer drug design. His research has become a widely cited reference in related studies, underscoring his scientific contributions’ value and relevance.

🌍IMPACT AND INFLUENCE

  • Dr. Zhou’s influence in the medicinal chemistry field is highlighted by his 100+ publications in high-impact journals, showcasing the scientific community’s recognition of his expertise. His achievements were honored in 2012 with the prestigious “Xiehe Star” award, recognizing his exceptional contributions to the field of drug design.

🌟LEGACY AND FUTURE AND CONTRIBUTIONS

  • As Dr. Zhou continues his work at the Drug Development and Innovation Center, he is shaping a new generation of researchers focused on tackling global health challenges. His legacy is built not only on his published works but also on his mentorship and role in expanding the field of drug innovation. His ongoing research promises to further the understanding of rational drug design and its applications in combating complex diseases.

📄Publications

  • “Inducing or enhancing protein-protein interaction to develop drugs: Molecular glues with various biological activity”
    Authors: Zhang, R., Zheng, Y., Xiang, F., Zhou, J.
    Journal: European Journal of Medicinal Chemistry, 2024, 277, 116756
  • “METTL3 inhibitor suppresses the progression of prostate cancer via IGFBP3/AKT pathway and synergizes with PARP inhibitor”
    Authors: Chen, X., Wang, M., Wang, H., Zhou, J., Wu, M.
    Journal: Biomedicine and Pharmacotherapy, 2024, 179, 117366
  • “Autophagy mediated targeting degradation, a promising strategy in drug development”
    Authors: Zhang, J., Pan, X., Ji, W., Zhou, J.
    Journal: Bioorganic Chemistry, 2024, 149, 107466
  • “A novel hydrophobic tag leads to the efficient degradation of programmed death-ligand 1”
    Authors: Gao, J., Xie, Y., Zhang, J., Cen, S., Zhou, J.
    Journal: RSC Medicinal Chemistry, 2024, 15(9), pp. 3038–3047
  • “Design and Synthesis of Dual-Target Inhibitors Targeting Androgen Receptors and Glucocorticoid Receptors to Overcome Antiandrogen Resistance in Castration-Resistant Prostate Cancer”
    Authors: Li, C., Han, X., Yan, Q., Wu, M., Zhou, J.
    Journal: Journal of Medicinal Chemistry, 2024, 67(5), pp. 3419–3436